tiprankstipranks
Advertisement
Advertisement

INMB Stock Latest News

Inmune Bio Advances CORDStrom Amid Funding Pressures
Company AnnouncementsInmune Bio Advances CORDStrom Amid Funding Pressures
1d ago
INMB
INmune Bio Expands Cord Tissue License for CORDStrom Platform
PremiumCompany Announcements
INmune Bio Expands Cord Tissue License for CORDStrom Platform
4d ago
8K
INMB
INmune Bio announces new preclinical data for INB03
PremiumThe Fly
INmune Bio announces new preclinical data for INB03
24d ago
INMB
Inmune Bio Earnings Call Balances Progress and Risk
PremiumCompany Announcements
Inmune Bio Earnings Call Balances Progress and Risk
1M ago
INMB
INMB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
INMB Upcoming Earnings Report: What to Expect?
1M ago
INMB
INmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s
PremiumThe FlyINmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s
2M ago
INMB
INmune Bio upgraded to Buy from Neutral at Lucid Capital
Premium
The Fly
INmune Bio upgraded to Buy from Neutral at Lucid Capital
2M ago
INMB
Inmune Bio Completes Early INKmune Trial in Advanced Prostate Cancer: What Investors Should Watch Next
Premium
Company Announcements
Inmune Bio Completes Early INKmune Trial in Advanced Prostate Cancer: What Investors Should Watch Next
2M ago
INMB
INmune Bio Highlights CORDStrom RDEB Program and IP Strength
PremiumCompany Announcements
INmune Bio Highlights CORDStrom RDEB Program and IP Strength
2M ago
8K
INMB
INmune Bio Advances XPro Toward Registrational Alzheimer’s Study
PremiumCompany Announcements
INmune Bio Advances XPro Toward Registrational Alzheimer’s Study
3M ago
8K
INMB
INmune Bio to Present New CORDStrom Phase III Data
PremiumCompany Announcements
INmune Bio to Present New CORDStrom Phase III Data
3M ago
8K
INMB
INmune Bio Advances CORDStrom Toward Rare Disease Commercialization
PremiumCompany Announcements
INmune Bio Advances CORDStrom Toward Rare Disease Commercialization
3M ago
8K
INMB
INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
PremiumRatingsINmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
3M ago
INMB
INmune Bio announces FDA alignment on phase 2b/3 registration pathway
Premium
The Fly
INmune Bio announces FDA alignment on phase 2b/3 registration pathway
3M ago
INMB
INmune Bio submits pre-submission package for CORDStrom with MHRA
Premium
The Fly
INmune Bio submits pre-submission package for CORDStrom with MHRA
3M ago
INMB
INmune Bio: Undervalued Pipeline with 2026 Clinical and Regulatory Catalysts Driving Buy Rating
PremiumRatings
INmune Bio: Undervalued Pipeline with 2026 Clinical and Regulatory Catalysts Driving Buy Rating
3M ago
INMB
INmune Bio outlines 2026 regulatory path in shareholder letter
PremiumCompany Announcements
INmune Bio outlines 2026 regulatory path in shareholder letter
3M ago
8K
INMB
INmune Bio CEO says ‘well positioned for continued execution’
PremiumThe Fly
INmune Bio CEO says ‘well positioned for continued execution’
3M ago
INMB
Inmune Bio Amends April 2024 Investor Warrants
PremiumCompany Announcements
Inmune Bio Amends April 2024 Investor Warrants
5M ago
8K
INMB
INmune Bio Establishes $65 Million At-The-Market Offering
PremiumCompany AnnouncementsINmune Bio Establishes $65 Million At-The-Market Offering
5M ago
8K
INMB
Inmune Bio Ends Sales Agreement with RBC and BTIG
Premium
Company Announcements
Inmune Bio Ends Sales Agreement with RBC and BTIG
5M ago
8K
INMB
Inmune Bio Unveils Promising Alzheimer’s Trial Data
Premium
Company Announcements
Inmune Bio Unveils Promising Alzheimer’s Trial Data
5M ago
8K
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >